Drug Type Molecular glue |
Synonyms- |
Target |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | KR | 22 May 2023 |